DK3468535T3 - Resveratrol-solubiliseringsprodukt til farmakologiske formål - Google Patents

Resveratrol-solubiliseringsprodukt til farmakologiske formål Download PDF

Info

Publication number
DK3468535T3
DK3468535T3 DK17702347.0T DK17702347T DK3468535T3 DK 3468535 T3 DK3468535 T3 DK 3468535T3 DK 17702347 T DK17702347 T DK 17702347T DK 3468535 T3 DK3468535 T3 DK 3468535T3
Authority
DK
Denmark
Prior art keywords
resveratrol
pharmacological purposes
solubilization product
solubilization
product
Prior art date
Application number
DK17702347.0T
Other languages
English (en)
Inventor
Dariush Behnam
Marshall A Hayward
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquanova Ag filed Critical Aquanova Ag
Application granted granted Critical
Publication of DK3468535T3 publication Critical patent/DK3468535T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17702347.0T 2016-06-14 2017-01-26 Resveratrol-solubiliseringsprodukt til farmakologiske formål DK3468535T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2016063579 2016-06-14
PCT/EP2017/051659 WO2017215791A1 (en) 2016-06-14 2017-01-26 Resveratrol solubilisation product for pharmaceutical purposes

Publications (1)

Publication Number Publication Date
DK3468535T3 true DK3468535T3 (da) 2020-07-06

Family

ID=57944408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17702347.0T DK3468535T3 (da) 2016-06-14 2017-01-26 Resveratrol-solubiliseringsprodukt til farmakologiske formål

Country Status (10)

Country Link
US (1) US10780056B2 (da)
EP (1) EP3468535B1 (da)
JP (1) JP6907243B2 (da)
CN (1) CN109562066B (da)
CA (1) CA3026810A1 (da)
DK (1) DK3468535T3 (da)
ES (1) ES2798403T3 (da)
HU (1) HUE049304T2 (da)
PL (1) PL3468535T3 (da)
WO (1) WO2017215791A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102228135B1 (ko) * 2018-07-19 2021-03-16 조선대학교산학협력단 레스베라트롤을 포함하는 고형 제제 형태의 약학 조성물 및 레스베라트롤의 가용화 방법
WO2023023323A1 (en) * 2021-08-20 2023-02-23 Jupiter Neurosciences, Inc. Resveratrol pharmaceutical compositions and methods of use thereof
CN113812552B (zh) * 2021-09-01 2023-12-26 江南大学 一种全营养固体饮料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101874763A (zh) * 2009-04-29 2010-11-03 上海家化联合股份有限公司 一种白藜芦醇柔性脂质体及其制备方法
WO2013120025A1 (en) * 2012-02-10 2013-08-15 Virun, Inc. Beverage compositions containing non-polar compounds
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US9861611B2 (en) * 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same

Also Published As

Publication number Publication date
PL3468535T3 (pl) 2020-09-07
WO2017215791A1 (en) 2017-12-21
HUE049304T2 (hu) 2020-09-28
EP3468535B1 (en) 2020-05-27
JP6907243B2 (ja) 2021-07-21
US10780056B2 (en) 2020-09-22
ES2798403T3 (es) 2020-12-11
CN109562066A (zh) 2019-04-02
EP3468535A1 (en) 2019-04-17
CN109562066B (zh) 2021-08-10
JP2019518047A (ja) 2019-06-27
CA3026810A1 (en) 2017-12-21
US20190307700A1 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
DK3034285T3 (da) Tætningsmiddeldispenser
FI20145090A (fi) Kuitupohjainen tuote
DK3468535T3 (da) Resveratrol-solubiliseringsprodukt til farmakologiske formål
DK3257589T3 (da) Dyse
DK3307076T3 (da) Podepartikelprodukt
BR112016025074A2 (pt) produto de espuma
DE112017003750A5 (de) Kolben-Zylinder-Einheit
CL2017000622S1 (es) Boquilla
UA34392S (uk) Пляшка
TH171685B (th) ที่ตัดเม็ดยา
UA33843S (uk) Пляшка
UA33606S (uk) Пляшка
UA33292S (uk) Пляшка
UA33838S (uk) Пляшка
UA33180S (uk) Пляшка
UA33173S (uk) Пляшка
UA33893S (uk) Пляшка
UA33725S (uk) Пляшка
ES1149784Y (es) Dispensador
UA33404S (uk) Пляшка
UA33332S (uk) Пляшка
UA32980S (uk) Флакон
UA33631S (uk) Пляшка
UA32964S (uk) Флакон
UA33138S (uk) Пляшка